Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis.
Natalizumab and fingolimod: Insight into their relative efficacies in clinical practice.
Multiple sclerosis update.
Neuromyelitis optica spectrum disorders: beyond longitudinally extensive transverse myelitis.
The analysis of semantic networks in multiple sclerosis identifies preferential damage of long-range connectivity.
Multicystic demyelinating myelopathy: Widening spectrum of pediatric aquaporin-4 autoimmunity.
Effects of Multiple Sclerosis on Female Sexuality: A Controlled Study.
Recovery From Central Nervous System Acute Demyelination in Children.
Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.
Analysis of tremor in multiple sclerosis using Hilbert-Huang Transform.
MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis.
Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis.
Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis.
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register.
A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis.
Chronic inflammatory demyelinating polyneuropathy associated with primary biliary cirrhosis.
Evidence for efficacy of a drug widely used without authorisation in multiple sclerosis: mycophenolate mofetil.
Physiological variation of retinal layer thickness is not caused by hydration: A randomised trial.
Vitamin D in allergic disorders.
[Effect of LINGO-1 gene silencing on movement function of EAE mice].
[Progressive multifocal leukoencephalopathy associated to natalizumab: the importance of magnetic resonance imaging in its early diagnosis].
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.
Pages
« first
‹ previous
…
435
436
437
438
439
440
441
442
443
…
next ›
last »